Pharvaris Announces Changes to its Board of Directors
ZUG, Switzerland, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization...
News
ZAGENO’s New Operations Leader Delivers Consumer Expertise from Apple
Kostas Sereleas Senior VP of Operations at ZAGENO CAMBRIDGE, Mass., Dec. 07, 2021 (GLOBE NEWSWIRE) -- ZAGENO, a leading enterprise...
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease
NEW YORK and SOLANA BEACH, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Cyprium Therapeutics, Inc. (“Cyprium”), a Fortress Biotech, Inc....
PepGen Appoints Vice President of Program Management and Promotes Sonia Bracegirdle, Ph.D., to Senior Vice President, Strategy & Operations
Dr. Bracegirdle to lead expanded PepGen Strategy and Operations teamIsami J. Salcedo, experienced biotechnology operations and program management professional, joins...
Recce Pharmaceuticals Announces Update on Phase I/II Clinical Trial for the Treatment of Burn Wound Infections
Highlights: Broad spectrum antibiotic activity on bacterial burn wound infections with visible infection reduction <24 hours on all patients to...
Gain Therapeutics Progresses Krabbe Disease Program and Provides Scientific Update
Data Show Statistically Significant Increases in GALC Enzyme and Depletion of Toxic Substrate PsychosineBETHESDA, Md., Dec. 07, 2021 (GLOBE NEWSWIRE) --...
Aligos Presents Update of Chronic Hepatitis B Pipeline Portfolio at HEP DART 2021
New data from HBeAg-positive patients receiving 100 mg of ALG-000184 demonstrates similar PK and potent antiviral activity to previously reported...
Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma
PALO ALTO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address...
Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece
Nes-Ziona, Israel, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV
Interim data from 27 patients, who had completed 3 months in the HBV002 study in chronic Hepatitis B (CHB) patients,...
Clover Signs COVID-19 Vaccine Supply Agreement with UNICEF
CHENGDU, China, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; Stock code: 2197.HK), a global clinical-stage biotechnology company...
Healthcare Triangle to Present at Sidoti December Virtual Microcap Conference
PLEASANTON, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company"), a leading provider...
Science 37® Furthers Global Expansion with Capabilities in China and Russia to Advance Decentralized Clinical Trials and Accelerate Development
Science 37 enhances its Operating Systems, adding ability to deploy its technology platform into China and Russia and strengthening global...
Harpoon Therapeutics to Host Pipeline Update Call and Webcast on December 13, 2021
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing...
Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement
Screening identifies several unique compound series that inhibit the SARS-CoV-2 nsp5 main protease, a validated target for the treatment of...
Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference
CARLSBAD, Calif. , Dec. 07, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB:...
CorVel Launches New Workers’ Compensation and Liability Solution, Leveraging Artificial Intelligence and Predictive Analytics
CogencyIQ helps risk managers and claims professionals navigate increasingly complex claims and massive amounts of data to improve outcomes for...
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial...
Advicenne announces significant progress in marketing its lead product Sibnayal™ in Europe
Advicenne announces significant progress in marketing its lead product Sibnayal™ in Europe First round of pricing negotiations completed in the...
Jushi Holdings Inc. Announces Participation in Upcoming Conferences in December 2021
BOCA RATON, Fla., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
